321
Participants
Start Date
March 14, 2023
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
Biospecimen Collection
Biospecimen Sample Collection
Medical University of Vienna, Vienna
Royal Prince Alfred Hospital, Camperdown
Haemophilia and Haemostasis Centre Level 1 Cancer Centre South Metropolitan Health Service Fiona Stanley Hospital, Murdoch
King Faisal Specialist Hospital & Research Center, Riyadh
Sheikh Shakhbout Medical City, Abu Dhabi
King Saud University Medical City King Saud University, Riyadh
Gaziantep University Medical Faculty Sahinbey Educational Research Hospital, Gaziantep
Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul
Ege University Medical Faculty, Izmir
Ondokuz Mayis Univ. Med. Fac., Samsun
Instituto Hematologia Arbesu, Godoy Cruz
Hospital Ramon Jose Vidal, Corrientes
Medico Hematologo, Mendoza
Instituto de Hematologia y Medicina Clinica Dr. RUben Davoli, Rosario
Skane University Hospital, Malmo
ME Centrum för kliniska cancerstudier - House H3, Solna
Acibadem Adana Hospital, Adana
Hacettepe University, Ankara
Lead Sponsor
BioMarin Pharmaceutical
INDUSTRY